Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa [9]

Journal of the American Academy of Dermatology

Volumn 50, Issue 5, 2004, Pages 803-804

  Hasegawa, Toshio ^a   Suga, Yasushi ^a   Mizoguchi, Masayuki ^a   Ikeda, Shigaku ^a   Ogawa, Hideoki ^a   Kubo, Kentaro ^b   Matsui, Hiromichi ^b   Kagawa, Shizuko ^b   Kuroyanagi, Yoshimitsu ^b  

^a JUNTENDO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRONECTIN; HYALURONIC ACID; VASCULOTROPIN;

ALLOGRAFT; CASE REPORT; CONSERVATIVE TREATMENT; DISEASE SEVERITY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPITHELIZATION; FIBROBLAST; GRANULATION TISSUE; HUMAN; HUMAN CELL; LETTER; PRIORITY JOURNAL; SKIN ULCER; TREATMENT INDICATION; TREATMENT OUTCOME; WOUND HEALING;

EID: 2342455836     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.08.013     Document Type: Letter

References (5)

1. Carter DM, Lin AN, Varghese MC, Caldwell D, Pratt LA, Elsinger M. Treatment of junctional epidermolysis bullosa with epidermal autografts. J Am Acad Dermatol 1987;17:246-50.
2. McGraph JA, Schofield OMV, Ishida-Yamamoto A, O'Grady A, Mayou BJ, Navsaria H, et al. Cultured keratinocyte allografts and wound healing in severe dystrophic epidermolysis bullosa. J Am Acad Dermatol 1993;29:407-19.
3. Kuroyanagi Y, Yamada N, Yamashita R, Uchinuma E. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif Organs 2001;25: 180-6.
4. Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in animal test. J Artif Organs 2003;6:64-70.
5. Kubo K, Kuroyanagi Y. Characterization of cultured dermal substitute composed of spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs 2003;6:138-44.